Judith Feld - May 19, 2023 Form 4 Insider Report for Ontrak, Inc. (OTRK)

Role
Chief Medical Officer
Signature
/s/ Judith Feld
Stock symbol
OTRK
Transactions as of
May 19, 2023
Transactions value $
$0
Form type
4
Date filed
5/24/2023, 06:08 AM
Previous filing
May 15, 2023
Next filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTRK Option (right to buy) Award +1K 1K May 19, 2023 Common Stock 1K $0.41 Direct F1, F2
transaction OTRK Option (right to buy) Disposed to Issuer -1K -100% 0 May 19, 2023 Common Stock 1K $5.74 Direct F1, F2
transaction OTRK Option (right to buy) Award +18.5K 18.5K May 19, 2023 Common Stock 18.5K $0.41 Direct F2, F3
transaction OTRK Option (right to buy) Disposed to Issuer -18.5K -100% 0 May 19, 2023 Common Stock 18.5K $1.73 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 200 of these shares vested on December 16, 2022 and the remaining shares vest equally on the last day of each quater beginning January 1, 2023 over the following four years, such that all shares shall be vested on December 16, 2026. There was no change to the vesting schedule in connection with the repricing transaction on May 19, 2023.
F2 The reporting person agreed to the repricing of options originally granted to her on December 16, 2021 and April 12, 2022.
F3 4,625 of these shares vested on April 12, 2023 and the remaining shares vest equally each quarter thereafter over the following three years, such that all shares shall be vested on April 12, 2026. There was no change to the vesting schedule in connection with the repricing transaction on May 19, 2023.